MedTrace Logo

Biologics for Stricturing Crohn's Diseases

NCT05645055 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-05-11

No results posted yet for this study

Summary

Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.

Conditions

  • The Efficacy of Biologics for Stricturing Crohn's Diseases

Interventions

OTHER

treat these patients with biologics

treat these patients with biologics

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Weiming wm Zhu, Ph.D. · Jinling Hospital, China

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-01-31
Completion
2029-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05645055 on ClinicalTrials.gov